RYTHMOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Rythmol, and what generic alternatives are available?
Rythmol is a drug marketed by Glaxosmithkline Llc and is included in two NDAs.
The generic ingredient in RYTHMOL is propafenone hydrochloride. There are eleven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the propafenone hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rythmol
A generic version of RYTHMOL was approved as propafenone hydrochloride by WATSON LABS on October 24th, 2000.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RYTHMOL?
- What are the global sales for RYTHMOL?
- What is Average Wholesale Price for RYTHMOL?
Summary for RYTHMOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 181 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,026 |
| Drug Prices: | Drug price information for RYTHMOL |
| What excipients (inactive ingredients) are in RYTHMOL? | RYTHMOL excipients list |
| DailyMed Link: | RYTHMOL at DailyMed |
Recent Clinical Trials for RYTHMOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| GlaxoSmithKline | Phase 1 |
| Medtronic | Phase 3 |
| Mayo Clinic | Phase 3 |
US Patents and Regulatory Information for RYTHMOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline Llc | RYTHMOL | propafenone hydrochloride | TABLET;ORAL | 019151-001 | Nov 27, 1989 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Glaxosmithkline Llc | RYTHMOL SR | propafenone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021416-001 | Sep 4, 2003 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Glaxosmithkline Llc | RYTHMOL | propafenone hydrochloride | TABLET;ORAL | 019151-003 | Nov 20, 1992 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Glaxosmithkline Llc | RYTHMOL | propafenone hydrochloride | TABLET;ORAL | 019151-002 | Nov 27, 1989 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Glaxosmithkline Llc | RYTHMOL SR | propafenone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021416-003 | Sep 4, 2003 | DISCN | Yes | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
